Please fill out the form below and we will gladly respond as soon as possible.
Zelluna ASA, a Norwegian biotech company pioneering allogeneic cell therapies for solid cancers, recently announced that the first patient has received the first dose of ZI-MA4-1 in the ZIMA-101 Phase 1 clinical trial. The treatment was administered at The Christie NHS Foundation Trust in Manchester, United Kingdom, the largest single-site cancer centre in Europe, marking […]
A landmark study from Jerby-Arnon, Neftel, Shore, and colleagues at the Broad Institute of Harvard and MIT, Massachusetts General Hospital, Dana-Farber Cancer Institute, and the University of Lausanne used single-cell RNA sequencing to profile 16,872 individual cells from 12 human synovial sarcoma tumors – one of the most detailed cellular portraits of this disease ever […]
A case report published in Frontiers in Oncology by Miyazaki, Oike, and colleagues at Niigata University Graduate School of Medical and Dental Sciences, Japan, documents a rare synovial sarcoma presentation that defeated every standard diagnostic test – and delayed correct treatment by over three years. The case carries urgent lessons for patients, advocates, and clinicians […]
